Is Roche Holding (SWX:ROG) Still Attractively Priced After Strong Three Year Share Gains? [Yahoo! Finance]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: Yahoo! Finance
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. If you are wondering whether Roche Holding's current share price reflects its true worth, this article will walk through the numbers in a clear and practical way. The stock most recently closed at CHF 358.80, with returns of 1.2% over 30 days and 10.2% year to date, while the 1 year and 3 year figures sit at 22.3% and 50.7% respectively. Recent news around Roche has centered on its position as a major global pharmaceuticals and biotech group, with investors watching how its product pipeline and diagnostics franchise feed into long term expectations. Headlines have also highlighted how large healthcare names can be treated as relatively defensive, which can influence how quickly sentiment shifts when new information emerges. On Simply Wall St's 6 point valuation checklist, Roche Holding scores 5 out of 6, which supports a closer look at how different valuation methods co
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- Genentech Announces Positive Phase II Results for Petrelintide, an Amylin Analog Developed for People Living With Overweight and Obesity [Yahoo! Finance]Yahoo! Finance
- Genentech Announces Positive Phase II Results for Petrelintide, an Amylin Analog Developed for People Living With Overweight and ObesityBusiness Wire
- Roche announces $481m investment in South Korean biotech sector [Yahoo! Finance]Yahoo! Finance
- Roche's Fenebrutinib MS Results Test Valuation And Growth Expectations [Yahoo! Finance]Yahoo! Finance